These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 10861266)

  • 1. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
    von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S
    Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.
    Kirkegaard T; Hansen A; Bruun E; Brynskov J
    Gut; 2004 May; 53(5):701-9. PubMed ID: 15082589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease.
    Altadill A; Eiró N; González LO; Junquera S; González-Quintana JM; Sánchez MR; Andicoechea A; Saro C; Rodrigo L; Vizoso FJ
    Inflamm Bowel Dis; 2012 Jan; 18(1):120-30. PubMed ID: 21438097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.
    Heuschkel RB; MacDonald TT; Monteleone G; Bajaj-Elliott M; Smith JA; Pender SL
    Gut; 2000 Jul; 47(1):57-62. PubMed ID: 10861265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
    Rath T; Roderfeld M; Graf J; Wagner S; Vehr AK; Dietrich C; Geier A; Roeb E
    Inflamm Bowel Dis; 2006 Nov; 12(11):1025-35. PubMed ID: 17075343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease.
    Meijer MJ; Mieremet-Ooms MA; van Duijn W; van der Zon AM; Hanemaaijer R; Verheijen JH; van Hogezand RA; Lamers CB; Verspaget HW
    Inflamm Bowel Dis; 2007 Feb; 13(2):200-10. PubMed ID: 17206679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
    Wang YD; Yan PY
    World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
    Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
    Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.
    Daum S; Bauer U; Foss HD; Schuppan D; Stein H; Riecken EO; Ullrich R
    Gut; 1999 Jan; 44(1):17-25. PubMed ID: 9862821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
    Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
    Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
    Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
    Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis.
    Mäkitalo L; Piekkala M; Ashorn M; Pakarinen M; Koivusalo A; Karikoski R; Natunen J; Saarialho-Kere U; Rintala R; Kolho KL
    World J Gastroenterol; 2012 Aug; 18(30):4028-36. PubMed ID: 22912554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
    Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
    Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
    Young KA; Hennebold JD; Stouffer RL
    Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
    Ma C; Chegini N
    Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease.
    Arihiro S; Ohtani H; Hiwatashi N; Torii A; Sorsa T; Nagura H
    Histopathology; 2001 Jul; 39(1):50-9. PubMed ID: 11454044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.
    Mäkitalo L; Kolho KL; Karikoski R; Anthoni H; Saarialho-Kere U
    Scand J Gastroenterol; 2010 Aug; 45(7-8):862-71. PubMed ID: 20367198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
    McKaig BC; McWilliams D; Watson SA; Mahida YR
    Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
    Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
    Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.